A multigene germline mutation analysis of ovarian cancer patients at the University of Washington revealed that 18% of patients carried pathogenic mutations in susceptibility genes and that PALB2 and BARD1 were significantly associated with the occurrence of ovarian cancer (19). Here, PALB2 is linked to ovarian carcinoma.